563 related articles for article (PubMed ID: 16127016)
21. The bile acid receptor FXR is a modulator of intestinal innate immunity.
Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
[TBL] [Abstract][Full Text] [Related]
22. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
23. Acid sphingomyelinase inhibition suppresses lipopolysaccharide-mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium-induced colitis in mice.
Sakata A; Ochiai T; Shimeno H; Hikishima S; Yokomatsu T; Shibuya S; Toda A; Eyanagi R; Soeda S
Immunology; 2007 Sep; 122(1):54-64. PubMed ID: 17451462
[TBL] [Abstract][Full Text] [Related]
24. Innate defenses of the intestinal epithelial barrier.
Müller CA; Autenrieth IB; Peschel A
Cell Mol Life Sci; 2005 Jun; 62(12):1297-307. PubMed ID: 15971105
[TBL] [Abstract][Full Text] [Related]
25. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.
Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603
[TBL] [Abstract][Full Text] [Related]
26. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
27. The changing immunological paradigm in coeliac disease.
Brandtzaeg P
Immunol Lett; 2006 Jun; 105(2):127-39. PubMed ID: 16647763
[TBL] [Abstract][Full Text] [Related]
28. CCR6 has a non-redundant role in the development of inflammatory bowel disease.
Varona R; Cadenas V; Flores J; Martínez-A C; Márquez G
Eur J Immunol; 2003 Oct; 33(10):2937-46. PubMed ID: 14515278
[TBL] [Abstract][Full Text] [Related]
29. Translational research in inflammatory bowel disease.
Abreu MT; Sparrow MP
Mt Sinai J Med; 2006 Dec; 73(8):1067-73. PubMed ID: 17285196
[TBL] [Abstract][Full Text] [Related]
30. Review article: the aetiopathogenesis of inflammatory bowel disease--immunology and repair mechanisms.
Dignass AU; Baumgart DC; Sturm A
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():9-17. PubMed ID: 15352888
[TBL] [Abstract][Full Text] [Related]
31. Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis.
Ohkawara T; Mitsuyama K; Takeda H; Asaka M; Fujiyama Y; Nishihira J
Scand J Gastroenterol; 2008; 43(12):1497-504. PubMed ID: 18663662
[TBL] [Abstract][Full Text] [Related]
32. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
[TBL] [Abstract][Full Text] [Related]
33. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.
Powrie F; Leach MW
Ther Immunol; 1995 Apr; 2(2):115-23. PubMed ID: 8729882
[TBL] [Abstract][Full Text] [Related]
34. Celiac disease pathogenesis: the proinflammatory cytokine network.
Garrote JA; Gómez-González E; Bernardo D; Arranz E; Chirdo F
J Pediatr Gastroenterol Nutr; 2008 Aug; 47 Suppl 1():S27-32. PubMed ID: 18667914
[TBL] [Abstract][Full Text] [Related]
35. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.
Powrie F; Uhlig H
Novartis Found Symp; 2004; 263():164-74; discussion 174-8, 211-8. PubMed ID: 15669641
[TBL] [Abstract][Full Text] [Related]
36. Immunopathogenesis of inflammatory bowel disease: current concepts.
Bamias G; Cominelli F
Curr Opin Gastroenterol; 2007 Jul; 23(4):365-9. PubMed ID: 17545770
[TBL] [Abstract][Full Text] [Related]
37. Helminths and mucosal immune modulation.
Weinstock JV
Ann N Y Acad Sci; 2006 Aug; 1072():356-64. PubMed ID: 17057216
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
[TBL] [Abstract][Full Text] [Related]
39. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation.
Clavel T; Haller D
Curr Issues Intest Microbiol; 2007 Sep; 8(2):25-43. PubMed ID: 17542334
[TBL] [Abstract][Full Text] [Related]
40. EC144, a synthetic inhibitor of heat shock protein 90, blocks innate and adaptive immune responses in models of inflammation and autoimmunity.
Yun TJ; Harning EK; Giza K; Rabah D; Li P; Arndt JW; Luchetti D; Biamonte MA; Shi J; Lundgren K; Manning A; Kehry MR
J Immunol; 2011 Jan; 186(1):563-75. PubMed ID: 21131419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
